Gail Folena-wasserman
Senior Vice President, Biopharmaceutical Developme
research
AstraZeneca
Ireland
Biography
Dr. Gail Folena-Wasserman is the Head of Biopharmaceutical Development at MedImmune, and has oversight of all analytical, process, formulation and drug product development including delivery and devices; and clinical manufacturing and quality control for clinical products. Dr. Folena-Wasserman is responsible for research support, early and late-stage development, clinical manufacturing phases I-III, technology transfer and life cycle management.
Research Interest
medicinal science